Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Acrux ( (AU:ACR) ) has shared an announcement.
Acrux Ltd has released its Appendix 4G and Corporate Governance Statement for the financial year ending June 30, 2025. This release, approved by the Board of Directors, highlights the company’s adherence to ASX Corporate Governance Council’s principles and recommendations, reflecting its commitment to transparency and regulatory compliance.
More about Acrux
Acrux is a specialty pharmaceutical company known for developing and commercializing topically applied pharmaceutical products. With 25 years of experience, the company has successfully marketed several products globally, particularly focusing on the United States.
Average Trading Volume: 482,787
Technical Sentiment Signal: Sell
Current Market Cap: A$6.14M
For an in-depth examination of ACR stock, go to TipRanks’ Overview page.